Avoid common mistakes on your manuscript.
1 Correction to: Drugs (2018) 78(14):1501–1508 https://doi.org/10.1007/s40265-018-0977-4
The article Elagolix: First Global Approval, written by Yvette N. Lamb, was originally published Online First without open access. After publication in volume 78, issue 14, pages 1501–1508 AbbVie Inc., requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by AbbVie Inc. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Open Access
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Lamb, Y.N. Correction to: Elagolix: First Global Approval. Drugs 78, 1855 (2018). https://doi.org/10.1007/s40265-018-1014-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-018-1014-3